nodes	percent_of_prediction	percent_of_DWPC	metapath
Methadyl Acetate—OPRM1—autistic disorder	0.964	1	CbGaD
Methadyl Acetate—OPRM1—telencephalic ventricle—autistic disorder	0.0131	0.433	CbGeAlD
Methadyl Acetate—OPRM1—brainstem—autistic disorder	0.00355	0.117	CbGeAlD
Methadyl Acetate—OPRM1—forebrain—autistic disorder	0.00343	0.113	CbGeAlD
Methadyl Acetate—OPRM1—telencephalon—autistic disorder	0.00315	0.104	CbGeAlD
Methadyl Acetate—OPRM1—head—autistic disorder	0.00196	0.0648	CbGeAlD
Methadyl Acetate—OPRM1—nervous system—autistic disorder	0.00186	0.0614	CbGeAlD
Methadyl Acetate—OPRM1—central nervous system—autistic disorder	0.00179	0.0591	CbGeAlD
Methadyl Acetate—OPRM1—brain—autistic disorder	0.00142	0.047	CbGeAlD
Methadyl Acetate—Tamoxifen—DHCR7—autistic disorder	0.00125	0.209	CrCbGaD
Methadyl Acetate—Diphenoxylate—OPRM1—autistic disorder	0.000844	0.142	CrCbGaD
Methadyl Acetate—Loperamide—POMC—autistic disorder	0.000812	0.137	CrCbGaD
Methadyl Acetate—Levomethadyl Acetate—OPRM1—autistic disorder	0.000425	0.0715	CrCbGaD
Methadyl Acetate—Dextropropoxyphene—OPRM1—autistic disorder	0.000367	0.0618	CrCbGaD
Methadyl Acetate—Loperamide—OPRM1—autistic disorder	0.00035	0.0588	CrCbGaD
Methadyl Acetate—Methadone—HTR3A—autistic disorder	0.000346	0.0582	CrCbGaD
Methadyl Acetate—Levomethadyl Acetate—CYP19A1—autistic disorder	0.000301	0.0505	CrCbGaD
Methadyl Acetate—Methadone—OPRM1—autistic disorder	0.000249	0.0419	CrCbGaD
Methadyl Acetate—Propiomazine—DRD1—autistic disorder	0.000233	0.0393	CrCbGaD
Methadyl Acetate—Phenoxybenzamine—ADRB2—autistic disorder	0.000187	0.0314	CrCbGaD
Methadyl Acetate—Tamoxifen—CYP19A1—autistic disorder	0.000178	0.0299	CrCbGaD
Methadyl Acetate—Methadone—CYP19A1—autistic disorder	0.000176	0.0296	CrCbGaD
Methadyl Acetate—Propiomazine—HTR2A—autistic disorder	0.000127	0.0214	CrCbGaD
Methadyl Acetate—Promethazine—HTR2A—autistic disorder	0.000107	0.018	CrCbGaD
Methadyl Acetate—OPRM1—IL4-mediated signaling events—EGR2—autistic disorder	6.29e-07	0.0495	CbGpPWpGaD
Methadyl Acetate—OPRM1—Peptide GPCRs—AVPR1A—autistic disorder	3.88e-07	0.0305	CbGpPWpGaD
Methadyl Acetate—OPRM1—Opioid Signalling—PDE4A—autistic disorder	3.85e-07	0.0303	CbGpPWpGaD
Methadyl Acetate—OPRM1—Peptide GPCRs—OXTR—autistic disorder	3.63e-07	0.0285	CbGpPWpGaD
Methadyl Acetate—OPRM1—Opioid Signalling—PDE4B—autistic disorder	3.1e-07	0.0244	CbGpPWpGaD
Methadyl Acetate—OPRM1—G-protein activation—POMC—autistic disorder	2.93e-07	0.023	CbGpPWpGaD
Methadyl Acetate—OPRM1—IL4-mediated signaling events—IL5—autistic disorder	2.91e-07	0.0229	CbGpPWpGaD
Methadyl Acetate—OPRM1—G alpha (i) signalling events—HTR5A—autistic disorder	2.48e-07	0.0195	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCRs, Class A Rhodopsin-like—HTR5A—autistic disorder	2.3e-07	0.0181	CbGpPWpGaD
Methadyl Acetate—OPRM1—IL4-mediated signaling events—IL10—autistic disorder	2.13e-07	0.0168	CbGpPWpGaD
Methadyl Acetate—OPRM1—G alpha (i) signalling events—GABBR2—autistic disorder	2.11e-07	0.0166	CbGpPWpGaD
Methadyl Acetate—OPRM1—IL4-mediated signaling events—IL4—autistic disorder	2.07e-07	0.0163	CbGpPWpGaD
Methadyl Acetate—OPRM1—IL4-mediated signaling events—ITGB3—autistic disorder	2.02e-07	0.0159	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR5A—autistic disorder	1.97e-07	0.0155	CbGpPWpGaD
Methadyl Acetate—OPRM1—G alpha (i) signalling events—HTR1D—autistic disorder	1.88e-07	0.0148	CbGpPWpGaD
Methadyl Acetate—OPRM1—Peptide ligand-binding receptors—AVPR1A—autistic disorder	1.82e-07	0.0143	CbGpPWpGaD
Methadyl Acetate—OPRM1—G alpha (i) signalling events—GRM8—autistic disorder	1.75e-07	0.0137	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCRs, Class A Rhodopsin-like—HTR1D—autistic disorder	1.74e-07	0.0137	CbGpPWpGaD
Methadyl Acetate—OPRM1—Opioid Signalling—PLA2G4A—autistic disorder	1.72e-07	0.0135	CbGpPWpGaD
Methadyl Acetate—OPRM1—Peptide ligand-binding receptors—OXTR—autistic disorder	1.71e-07	0.0134	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—HTR5A—autistic disorder	1.5e-07	0.0118	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR1D—autistic disorder	1.49e-07	0.0118	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCRs, Class A Rhodopsin-like—AVPR1A—autistic disorder	1.43e-07	0.0112	CbGpPWpGaD
Methadyl Acetate—OPRM1—G alpha (i) signalling events—GABBR1—autistic disorder	1.36e-07	0.0107	CbGpPWpGaD
Methadyl Acetate—OPRM1—Peptide ligand-binding receptors—OXT—autistic disorder	1.35e-07	0.0106	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCRs, Class A Rhodopsin-like—OXTR—autistic disorder	1.34e-07	0.0105	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—GABBR2—autistic disorder	1.28e-07	0.01	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—AVPR1A—autistic disorder	1.22e-07	0.00962	CbGpPWpGaD
Methadyl Acetate—OPRM1—Opioid Signalling—POMC—autistic disorder	1.22e-07	0.00957	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—OXTR—autistic disorder	1.14e-07	0.009	CbGpPWpGaD
Methadyl Acetate—OPRM1—G alpha (i) signalling events—HTR1B—autistic disorder	1.14e-07	0.00896	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—HTR1D—autistic disorder	1.14e-07	0.00895	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—GRM8—autistic disorder	1.06e-07	0.00832	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCRs, Class A Rhodopsin-like—HTR1B—autistic disorder	1.06e-07	0.00831	CbGpPWpGaD
Methadyl Acetate—OPRM1—G alpha (i) signalling events—DRD3—autistic disorder	1.03e-07	0.00807	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—WNT2—autistic disorder	1.02e-07	0.00806	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCRs, Class A Rhodopsin-like—DRD1—autistic disorder	9.82e-08	0.00773	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCRs, Class A Rhodopsin-like—DRD3—autistic disorder	9.51e-08	0.00748	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—AVPR1A—autistic disorder	9.31e-08	0.00733	CbGpPWpGaD
Methadyl Acetate—OPRM1—Peptide ligand-binding receptors—AVP—autistic disorder	9.25e-08	0.00728	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—OXT—autistic disorder	9.05e-08	0.00712	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR1B—autistic disorder	9.05e-08	0.00712	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—GRM5—autistic disorder	9e-08	0.00708	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—OXTR—autistic disorder	8.71e-08	0.00685	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—SCT—autistic disorder	8.62e-08	0.00678	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—HTR5A—autistic disorder	8.49e-08	0.00668	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD1—autistic disorder	8.42e-08	0.00662	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—ADM—autistic disorder	8.23e-08	0.00647	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—GABBR1—autistic disorder	8.23e-08	0.00647	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD3—autistic disorder	8.15e-08	0.00641	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCRs, Class A Rhodopsin-like—ADRB2—autistic disorder	7.71e-08	0.00606	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—HTR5A—autistic disorder	7.71e-08	0.00606	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—GABBR2—autistic disorder	7.22e-08	0.00568	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—HTR1B—autistic disorder	6.89e-08	0.00542	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—OXT—autistic disorder	6.89e-08	0.00542	CbGpPWpGaD
Methadyl Acetate—OPRM1—Opioid Signalling—MAPK1—autistic disorder	6.88e-08	0.00541	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—ADRB2—autistic disorder	6.6e-08	0.0052	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—GABBR2—autistic disorder	6.55e-08	0.00515	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—HTR1D—autistic disorder	6.43e-08	0.00506	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—DRD1—autistic disorder	6.41e-08	0.00504	CbGpPWpGaD
Methadyl Acetate—OPRM1—TCR Signaling Pathway—MAPK1—autistic disorder	6.32e-08	0.00497	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—DRD3—autistic disorder	6.21e-08	0.00488	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—AVP—autistic disorder	6.21e-08	0.00488	CbGpPWpGaD
Methadyl Acetate—OPRM1—Peptide ligand-binding receptors—POMC—autistic disorder	6.15e-08	0.00484	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCRs, Class A Rhodopsin-like—HTR2A—autistic disorder	6.03e-08	0.00474	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—CALCA—autistic disorder	6e-08	0.00472	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—GRM8—autistic disorder	5.98e-08	0.0047	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—HTR1D—autistic disorder	5.84e-08	0.00459	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—PDE4A—autistic disorder	5.62e-08	0.00442	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—GRM8—autistic disorder	5.43e-08	0.00427	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—AVPR1A—autistic disorder	5.26e-08	0.00414	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—WNT2—autistic disorder	5.26e-08	0.00414	CbGpPWpGaD
Methadyl Acetate—OPRM1—G alpha (i) signalling events—POMC—autistic disorder	5.19e-08	0.00408	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—autistic disorder	5.16e-08	0.00406	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—PDE4A—autistic disorder	5.1e-08	0.00402	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—GRM5—autistic disorder	5.08e-08	0.004	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—VIP—autistic disorder	5.08e-08	0.004	CbGpPWpGaD
Methadyl Acetate—OPRM1—TCR Signaling Pathway—HRAS—autistic disorder	5.07e-08	0.00399	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—ADRB2—autistic disorder	5.03e-08	0.00396	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—OXTR—autistic disorder	4.92e-08	0.00387	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—SCT—autistic disorder	4.87e-08	0.00383	CbGpPWpGaD
Methadyl Acetate—OPRM1—TCR Signaling Pathway—IL6—autistic disorder	4.86e-08	0.00382	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—AVPR1A—autistic disorder	4.78e-08	0.00376	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—NRP2—autistic disorder	4.75e-08	0.00374	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—AVP—autistic disorder	4.73e-08	0.00372	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—ADM—autistic disorder	4.65e-08	0.00366	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—GABBR1—autistic disorder	4.65e-08	0.00366	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—VIP—autistic disorder	4.62e-08	0.00363	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—GRM5—autistic disorder	4.62e-08	0.00363	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—HTR5A—autistic disorder	4.55e-08	0.00358	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—PDE4B—autistic disorder	4.53e-08	0.00356	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—OXTR—autistic disorder	4.47e-08	0.00352	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—SCT—autistic disorder	4.43e-08	0.00348	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—GABBR1—autistic disorder	4.22e-08	0.00332	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—ADM—autistic disorder	4.22e-08	0.00332	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—POMC—autistic disorder	4.12e-08	0.00324	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—PDE4B—autistic disorder	4.11e-08	0.00324	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—HTR2A—autistic disorder	3.93e-08	0.00309	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—OXT—autistic disorder	3.9e-08	0.00306	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—HTR1B—autistic disorder	3.9e-08	0.00306	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—GABBR2—autistic disorder	3.87e-08	0.00304	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—DRD1—autistic disorder	3.62e-08	0.00285	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—HTR1B—autistic disorder	3.54e-08	0.00278	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—OXT—autistic disorder	3.54e-08	0.00278	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—DRD3—autistic disorder	3.51e-08	0.00276	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—HTR1D—autistic disorder	3.45e-08	0.00271	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—IL5—autistic disorder	3.43e-08	0.0027	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—CALCA—autistic disorder	3.39e-08	0.00267	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—PRLR—autistic disorder	3.32e-08	0.00261	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—DRD1—autistic disorder	3.29e-08	0.00259	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—GRM8—autistic disorder	3.21e-08	0.00252	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—DRD3—autistic disorder	3.19e-08	0.00251	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—POMC—autistic disorder	3.14e-08	0.00247	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—IL5—autistic disorder	3.12e-08	0.00245	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—WNT2—autistic disorder	3.11e-08	0.00244	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—CALCA—autistic disorder	3.08e-08	0.00242	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—GHR—autistic disorder	3.06e-08	0.00241	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—PDE4A—autistic disorder	3.02e-08	0.00237	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—ADRB2—autistic disorder	2.84e-08	0.00224	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—AVPR1A—autistic disorder	2.82e-08	0.00222	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—GRM5—autistic disorder	2.73e-08	0.00215	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—VIP—autistic disorder	2.73e-08	0.00215	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—AVP—autistic disorder	2.67e-08	0.0021	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—OXTR—autistic disorder	2.64e-08	0.00208	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—SCT—autistic disorder	2.61e-08	0.00206	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—ADRB2—autistic disorder	2.58e-08	0.00203	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—GABBR1—autistic disorder	2.49e-08	0.00196	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—ADM—autistic disorder	2.49e-08	0.00196	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—EIF4E—autistic disorder	2.45e-08	0.00193	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—PDE4B—autistic disorder	2.43e-08	0.00191	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—AVP—autistic disorder	2.42e-08	0.00191	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—PLA2G4A—autistic disorder	2.28e-08	0.00179	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—HTR2A—autistic disorder	2.22e-08	0.00175	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—GZMB—autistic disorder	2.15e-08	0.00169	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—OXT—autistic disorder	2.09e-08	0.00164	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—HTR1B—autistic disorder	2.09e-08	0.00164	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—HTR2A—autistic disorder	2.02e-08	0.00159	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—PRKCB—autistic disorder	1.95e-08	0.00153	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—TSC1—autistic disorder	1.94e-08	0.00153	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—DRD1—autistic disorder	1.94e-08	0.00153	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—NTRK2—autistic disorder	1.89e-08	0.00149	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—DRD3—autistic disorder	1.88e-08	0.00148	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—PIK3CG—autistic disorder	1.86e-08	0.00147	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—IL5—autistic disorder	1.84e-08	0.00145	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CALCA—autistic disorder	1.82e-08	0.00143	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—POMC—autistic disorder	1.77e-08	0.0014	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—PRKCB—autistic disorder	1.77e-08	0.00139	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—PIK3CG—autistic disorder	1.69e-08	0.00133	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—POMC—autistic disorder	1.61e-08	0.00127	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—PRL—autistic disorder	1.61e-08	0.00126	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—ADRB2—autistic disorder	1.52e-08	0.0012	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—AVP—autistic disorder	1.43e-08	0.00113	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—IGF2—autistic disorder	1.43e-08	0.00112	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—PLA2G4A—autistic disorder	1.35e-08	0.00106	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—IL2—autistic disorder	1.31e-08	0.00103	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—MEF2C—autistic disorder	1.31e-08	0.00103	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—ITGB3—autistic disorder	1.28e-08	0.001	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—HTR2A—autistic disorder	1.19e-08	0.000938	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—IL2—autistic disorder	1.19e-08	0.000937	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—TSC2—autistic disorder	1.13e-08	0.000891	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—LEP—autistic disorder	1.11e-08	0.000872	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—APOE—autistic disorder	1.11e-08	0.000872	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—PRKCB—autistic disorder	1.05e-08	0.000822	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—APC—autistic disorder	1e-08	0.000787	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—PIK3CG—autistic disorder	1e-08	0.000787	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—EGF—autistic disorder	9.89e-09	0.000778	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—POMC—autistic disorder	9.52e-09	0.000749	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—IGF1—autistic disorder	9.16e-09	0.00072	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—MAPK1—autistic disorder	9.11e-09	0.000717	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—SERPINE1—autistic disorder	8.7e-09	0.000684	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—HRAS—autistic disorder	7.32e-09	0.000576	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—IL2—autistic disorder	7.04e-09	0.000554	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—IL6—autistic disorder	7e-09	0.000551	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—PTEN—autistic disorder	6.62e-09	0.000521	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—MAPK1—autistic disorder	5.38e-09	0.000423	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—HRAS—autistic disorder	4.32e-09	0.00034	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—IL6—autistic disorder	4.14e-09	0.000325	CbGpPWpGaD
